Covid-19 vaccine: China's Sinovac gets nod for emergency use in kids, adolescents

Preliminary results from Phase I and II clinical trials showed the vaccine could trigger immune response in three to 17-year-old participants.

Related Keywords

China ,Weidong ,Anhui , ,Sinovac Biotech ,Yin Weidong ,Cansino Biologic ,Kids ,Adolescents ,Sinovac ,Uae News ,Dubai News ,Coronavirus ,Uae Covid Vaccine ,Oxford Vaccines ,India Vaccine Uae ,Sputnik V ,Inopharm ,Oxford Astrazeneca ,Pfizer Biontech ,சீனா ,அன்ஹுய் ,கேன்சினோ உயிரியல் ,கீட்ஸ் ,ஏ செய்தி ,